Publication

[PLOS One] Human colon cancer cells were used to establish intestinal epithelial injury models with the urea treatment in different conditions.

[Molecular Cancer] The authors suggested that Pioglitazone reduces prostate cancer (PCa) cell proliferation and induces metabolic and epithelial changes, highlighting the potential of repurposing metabolic drugs for PCa therapy.

[International Journal of Biological Macromolecules] Researchers investigated the roles of calcium/calmodulin-dependent serine protein kinase in prostate cancer (PCa) progression, cell migration, and invasion. They found that CASK is up-regulated in PCa tissues of patients.

[Ecotoxicology and Environmental Safety] To explore the relationship between antimony exposure and cell proliferation, scientists found that the level of ceramide-1-phosphate (C1P), one of the metabolites of ceramide, increased after antimony exposure, and C1P can promote the proliferation of prostate cancer cells and antagonize the apoptosis induced by ceramide.

[Analyst] Fourier transform infrared imaging coupled with fluorescence microscopy was used to follow arachidonic acid metabolism in prostate cancer cell lines.

[Scientific Reports] Scientists demonstrated that Sinularin triggers autophagy via two different mechanisms in prostate cancer cells.